Symptomatic gastro-oesophageal reflux disease: double blind controlled study of intermittent treatment with omeprazole or ranitidine. The European Study Group
about
Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux diseaseMedical treatments for the maintenance therapy of reflux oesophagitis and endoscopic negative reflux diseaseShort-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux diseaseMedical treatments for the maintenance therapy of reflux oesophagitis and endoscopic negative reflux diseaseShort-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux diseaseProton pump inhibitors. Compliance with a mandated step-up programEsomeprazole treatment of frequent heartburn: two randomized, double-blind, placebo-controlled trials.Nonerosive reflux disease--current concepts and dilemmas.Dyspepsia, peptic ulcer disease, and esophageal reflux diseaseHeartburn treatment in primary care. Prescribing omeprazole would conflict with desire to control prescribing costs.Symptomatic reflux disease: the present, the past and the future.Management of gastro-oesophageal reflux disease in general practiceTrends, controversies and contradictions in the management of gastroesophageal reflux disease patients.Endoscopy-negative reflux disease.Proton pump inhibitors: update on their role in acid-related gastrointestinal diseases.The clinical and economic impact of competing management strategies for gastro-oesophageal reflux disease.Management of reflux disease.Review article: cost-effectiveness of different GERD management strategies.Short-term treatment of gastroesophageal reflux disease.Patient-centred endpoints in economic evaluations of gastro-oesophageal reflux disease.Acid suppression in gastro-oesophageal reflux disease: Why? How? How much and when?Republished: symptomatic reflux disease: the present, the past and the future.Proton pump inhibitor for non-erosive reflux disease: a meta-analysis.Overview: initial and long-term management of gastro-oesophageal reflux disease.The economic and quality-of-life impact of symptomatic gastroesophageal reflux disease.Intermittent and on-demand use of proton pump inhibitors in the management of symptomatic gastroesophageal reflux disease.New developments in the pathophysiology of gastro-oesophageal reflux disease (GERD): implications for patient management.Report of the Asia-Pacific consensus on the management of gastroesophageal reflux disease.Unmet Needs in the Treatment of Gastroesophageal Reflux Disease.Personal view: rationale and proposed algorithms for symptom-based proton pump inhibitor therapy for gastro-oesophageal reflux disease.Review article: diagnosis and management of night-time reflux.Systematic review: Is there excessive use of proton pump inhibitors in gastro-oesophageal reflux disease?Difference in efficacy of proton pump inhibitor between new-onset and recurrent gastroesophageal reflux disease: Result from a study of on-demand versus continuous maintenance therapy in JapanSystematic review: the efficacy of intermittent and on-demand therapy with histamine H2-receptor antagonists or proton pump inhibitors for gastro-oesophageal reflux disease patients.Treatment of uncomplicated reflux diseaseReview article: gastro-oesophageal reflux disease--the health economic implications.Review article: alternative approaches to the long-term management of GERD.Review article: the role of acid suppression in patients with non-erosive reflux disease or functional heartburn.Long-term management of GERD in the elderly with pantoprazole.Clinical trial design in adult reflux disease: a methodological workshop.
P2860
Q24236493-8A4DB377-2B64-4DA5-A490-5936B3F40CCCQ24240101-E8647026-86BF-43DA-834A-6FFE141C4768Q24245237-0977847A-F1D6-4A8D-ADDA-1D85CF2E0250Q24245681-A39F4E16-4A0F-4256-956C-925B2AE966F8Q24246801-3C484350-9C0D-4F4E-AB4F-E2F0D3869918Q28361663-0AD7DFD7-C0D0-457E-BAF6-47DC86F28050Q30458922-51F27700-5BC8-42C7-A06B-B04F1381B397Q32090261-40187C9D-968E-44E4-919E-FF25F33A3E19Q33729631-E367761D-AABF-4C39-9C04-2C813643D136Q33801030-39B83427-B578-4268-8B13-7B112CB9AB21Q33834731-2034637D-8D94-44CF-A312-9088A2ECDE7BQ34131661-BF935B56-347B-43A2-9E33-BF5B465F1BC5Q34152231-211326D0-3739-4A1A-B772-7455259F5AA7Q34251261-79771F90-4ECF-4FA6-9468-DD4F49EEE56DQ34422403-D0FBA622-5CA6-491D-8FB7-186E76DB700EQ34541695-49A509BC-633C-4655-8812-42FE6590BF19Q34601094-9C01710E-FE6B-4BF3-AB1E-034CDA49C6E6Q34669268-952DDCFE-31B4-4C48-9E17-745DC8910E92Q34742191-62B0E33E-98E4-4970-B71D-9ED66D36BDFCQ34786709-6401C31C-6BAF-43EF-BA17-9B29C1A59C46Q34788219-BE7260FB-D42E-4D51-A2DA-6215206FCCBDQ35048270-45DA2846-4566-4369-A43C-01B226E2B9EAQ35074278-5174692A-A85C-425A-8D84-FB370BE3D49DQ35076653-461DC91E-EA5E-4F3D-A229-C3FC6FB640FCQ35087968-602FC51A-30BC-4E3D-A6D7-7CB010CAB6DFQ35087986-A4DD7E6C-7219-4268-B269-2DBA44C42768Q35145028-94A85AE3-317D-4CC0-9678-C7517445DDF2Q35687664-EE48F9FF-F6C6-4125-A352-DB7337D93410Q35834504-6C3D5FB2-E451-4970-BE06-AD71AF4BB24DQ35857847-811544E5-6EC1-443C-B93F-1D3C1113D260Q35939808-1CDC9C4C-576A-470A-9EEB-09241F0F5493Q35987877-7A39AE31-7EB2-4802-9304-71AEC3298D1EQ36071963-BA321D11-C96F-4536-820A-FB66FC512D0BQ36149059-4F4648D5-1189-4775-8760-FC96A3327491Q36204260-E6F769D8-2C7F-4DAD-B13C-D94BCBD23CBFQ36206570-9523DC0F-8F72-435E-94A8-13E2FB4861F0Q36319540-10BC677A-E53D-408B-9AA5-3DFF64D21D88Q36398683-C5F355B2-73D9-4497-870A-FA2DCA9EEE32Q37017283-02631C81-B2E9-418D-9F08-45743DD88914Q37126867-ED5C6291-5D94-46B4-B14F-67721D365B57
P2860
Symptomatic gastro-oesophageal reflux disease: double blind controlled study of intermittent treatment with omeprazole or ranitidine. The European Study Group
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on February 1999
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Symptomatic gastro-oesophageal ...... dine. The European Study Group
@en
Symptomatic gastro-oesophageal ...... ine. The European Study Group.
@nl
type
label
Symptomatic gastro-oesophageal ...... dine. The European Study Group
@en
Symptomatic gastro-oesophageal ...... ine. The European Study Group.
@nl
prefLabel
Symptomatic gastro-oesophageal ...... dine. The European Study Group
@en
Symptomatic gastro-oesophageal ...... ine. The European Study Group.
@nl
P2093
P2860
P356
P1433
P1476
Symptomatic gastro-oesophageal ...... dine. The European Study Group
@en
P2093
G Bianchi Porro
K D Bardhan
K R Gillon
M A Bigard
R A Peacock
P2860
P304
P356
10.1136/BMJ.318.7182.502
P407
P577
1999-02-01T00:00:00Z